nVerses Capital’s Nuvalent NUVL Stock Holding History

nVerses Capital’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-300	Closed	-$22.8K	–	1278
2024 Q2	$22.8K	Buy	+300	New	+$21.3K	0.01%	771

Other funds holding NUVL

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

nVerses Capital's NUVL Position: Q3 2024 in Review

nVerses Capital sold out of Nuvalent (NUVL) in Q3 2024, closing a stake of 300 shares — an estimated $22.8K sold.

nVerses Capital first reported a position in NUVL in Q2 2024 and held it in 1 quarter. The position peaked at $22.8K in Q2 2024. 193 funds tracked by Wall St. Rank hold NUVL as of Q3 2024.

nVerses Capital reported no remaining Nuvalent position as of Q3 2024 after selling out during the quarter.
nVerses Capital sold 300 Nuvalent shares in Q3 2024, an estimated $22.8K.
nVerses Capital first reported a position in Nuvalent in Q2 2024 and held it in 1 quarter.
nVerses Capital's Nuvalent position peaked at $22.8K in Q2 2024.
193 funds tracked by Wall St. Rank held Nuvalent as of Q3 2024.

Based on nVerses Capital's 13F filing for Q3 2024, filed 16 Oct 2024.